Thor Medical ASA (OSL:TRMED)

Thor Medical ASA Statistics

Total Valuation

OSL:TRMED has a market cap or net worth of NOK 1.77 billion. The enterprise value is 1.76 billion.

Market Cap	1.77B
Enterprise Value	1.76B

Important Dates

The next confirmed earnings date is Friday, August 28, 2026.

Earnings Date	Aug 28, 2026
Ex-Dividend Date	n/a

Share Statistics

OSL:TRMED has 361.38 million shares outstanding. The number of shares has increased by 40.80% in one year.

Current Share Class	361.38M
Shares Outstanding	361.38M
Shares Change (YoY)	+40.80%
Shares Change (QoQ)	+13.99%
Owned by Insiders (%)	9.65%
Owned by Institutions (%)	4.68%
Float	104.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,106.27
PB Ratio	3.88
P/TBV Ratio	9.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.30
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.57

Financial Position

The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.38.

Current Ratio	4.57
Quick Ratio	4.46
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	-1.42
Interest Coverage	-115.70

Financial Efficiency

Return on equity (ROE) is -14.63% and return on invested capital (ROIC) is -9.02%.

Return on Equity (ROE)	-14.63%
Return on Assets (ROA)	-7.75%
Return on Invested Capital (ROIC)	-9.02%
Return on Capital Employed (ROCE)	-10.47%
Weighted Average Cost of Capital (WACC)	2.86%
Revenue Per Employee	46,611
Profits Per Employee	-3.22M
Employee Count	13
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-4.26M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +102.07% in the last 52 weeks. The beta is -0.21, so OSL:TRMED's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	+102.07%
50-Day Moving Average	4.65
200-Day Moving Average	3.80
Relative Strength Index (RSI)	57.85
Average Volume (20 Days)	2,448,338

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:TRMED had revenue of NOK 839,000 and -58.01 million in losses. Loss per share was -0.17.

Revenue	839,000
Gross Profit	839,000
Operating Income	-69.65M
Pretax Income	-62.27M
Net Income	-58.01M
EBITDA	-50.13M
EBIT	-69.65M
Loss Per Share	-0.17

Balance Sheet

The company has 180.56 million in cash and 171.38 million in debt, with a net cash position of 9.18 million or 0.03 per share.

Cash & Cash Equivalents	180.56M
Total Debt	171.38M
Net Cash	9.18M
Net Cash Per Share	0.03
Equity (Book Value)	456.00M
Book Value Per Share	1.29
Working Capital	155.86M

Cash Flow

In the last 12 months, operating cash flow was -47.54 million and capital expenditures -73.11 million, giving a free cash flow of -120.65 million.

Operating Cash Flow	-47.54M
Capital Expenditures	-73.11M
Depreciation & Amortization	19.52M
Net Borrowing	-1.08M
Free Cash Flow	-120.65M
FCF Per Share	-0.33

Margins

Gross Margin	100.00%
Operating Margin	-8,301.91%
Pretax Margin	-7,421.69%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OSL:TRMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.80%
Shareholder Yield	-40.80%
Earnings Yield	-3.28%
FCF Yield	-6.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OSL:TRMED has an Altman Z-Score of 2.06 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.06
Piotroski F-Score	1